chrisvoncsefalvay/vaers-outcomes huggingface dataset:
No adverse effects reported.; an unspecified number of patients received improperly stored dose of RECOMBIVAX, GARDASIL 9, MMRII, or PROQUAD; The report was first received from a practice manager on 07-SEP-2018, and it was recognized as non-valid because report did not obtain any patient identify.  Follow-up information has been received from the practice manager on 18-SEP-2018.  This spontaneous report refers to a patient of unknown age and gender. Information of concurrent condition, medical history and concomitant therapy was not provided.       On 09-APR-2018, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (strength and route were unknown) (lot# reported as No14633 which was verified as not valid and expiration date reported as 07-NOV-2018) for prophylaxis (Incorrect product storage). The sterile diluent (MERCK STERILE DILUENT) was properly stored. No adverse event was reported.  The excursion temperature on 22-SEP-2017, 17-OCT-2017, 06-DEC-2017, 07-DEC-2017, 30-JAN-2018, 23-FEB-2018, 18-MAY-2018, 05-JUL-2018, 15-AUG-2018 was 6 degree Celsius for maximize 8.75 hours. The excursion temperature on 02-MAR-2018, 27-AUG-2018 was 7 degree Celsius for maximize 8.75 hours. The excursion temperature on 07-DEC-2017 was 8 degree Celsius for maximize 15 hours. The call was not because of data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1809USA003709: US-009507513-1810USA001951: US-009507513-1810USA001952: US-009507513-1810USA001953: US-009507513-1810USA001954: US-009507513-1810USA001955: US-009507513-1810USA001956: US-009507513-1810USA001957: US-009507513-1810USA001959:
I had diarrhea, extreme chills, slight cough, and an extremely dry mouth. After getting about 12 hours of sleep, I woke up feeling totally normal.
Patient reports pain radiating down and through left arm without regard to activity or time of day since the time of vaccination.
he was admitted to the hospital 2 years ago for a concussion; Information has been received from a male physician (podiatrist) of unknown age, referring to himself. The patient's concomitant medication, concurrent condition, pertinent medical history and drug reactions/allergies were unknown.  On 05-NOV-2007, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (not valid lot# was reported as 0964V, dose, frequency, route, expiration date unknown) for prophylaxis.         In October 2017 (reported as 2 years ago), the patient was admitted to the hospital for a concussion. The outcome of concussion was unknown. The causality between pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) and concussion was unknown.
Is taking Augmentin for COVID with possible secondary infection of PNA. COVID positive January 1st, symptoms started on December 31. Will finish Augmentin in 6 days.
Rash starting (R) leg around injection site; moved up torso to cheeks 24 hrs. post immunization. Rash faded 3-4 days later; Afebrile.
Patient was slightly nervous before getting the vaccines. After administering the Flublok flu shot and Comirnaty Pfizer vaccine at 2:04pm in the left arm, patient began feeling uneasy.  I brought her a Gatorade to sip if needed. She described her feelings as:  Feeling of faintness, numbness in left arm, rapid heart rate. Store assistance was called. They arrived and called 911. Patient was still conscience as paramedics arrived and took her to the ambulance.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild.
sore throat, coughing, congestion, pain in chest and side/back after coughing for long periods, wheezing, fatigue, cold sweats/chills, sinus infection. given z-pack, told to continue sinus treatment regimen and allergy medication
Approximately 12 hours post-administration, I experienced body aches, chills, and a fever of 100.5° which persisted for 8 hours. Fatigue and headache persisted for approximately 24 hours post-administration.  Tenderness at injection site lasted 24 hours as well.
Swelling of the torso and enlarging movement of the rib bones. Intense sun tanning and shock to the skin particularly of the face and neck. Violent seizuring, dry heaving and vomiting, moral doubt in self, more skin and rib damage, more shock to the original quality of the eyes and facial features, feelings of vicious intended rape, a consequence of feeling that I have violated my faith.
Adverse events: cramping at injection site (deltoid), cramping in injection arm, general body cramping, muscle spasms, numbness, body temperature dropping, high fever (101F), chills, severe headache, excessive sweating, severe earache, lethargy, loss of appetite, loss of balance, dizziness, vertigo, joint pain (knees), altered sense of smell (acidic smoke), altered sense of taste (metallic), altered color vision (tinted yellow), altered mouthfeel (plastic film feeling), gum sensitivity, blotchy rashes (legs), tightness in chest, difficulty breathing. All occurred within first 48 hours following injection and began to subside without intervention prior to 72 hours following injection.
This spontaneous report as received from a healthcare professional refers to unspecified patients of unknown age and gender. On an unknown dates the patients were vaccinated with a dose of ROTATEQ (orally, doses and lot numbers not reported) that were improperly stored. No adverse symptoms reported. The temperature excursions with these vaccines were found to be supported with in-house stability data. This is one of several reports from the same source. Additional information has been requested.
Patient received monovalent  Pfizer instead of bivalent Pfizer. No adverse side effects to report.
100.0 fever, aches, chills, nausea, headache, sore arm, fatigue. last night had trouble breathing
After I had the vaccine, the next day by noon I started to feel awful I was achy, tired and came home and went to bed and I ached from the top of my head to my toes and I was like that all day till about Sunday afternoon and woke up Monday and went to work and everything was fine and in August I started getting pains that felt like they did after the vaccine and it started in my groin area and it spread to other parts of my body and finally in Oct I went to see the Dr. and she didn't prescribe any medications to me but started me on physical therapy and it didn't get any better it got worse and I called back and I seen another doctor and she did some testing and started me on prednisone and sent me to rheumatologist and he changed to me from prednisone to Medrol and I have been on it ever since. They also sent me to orthopedics, cardiologist, and pulmonology physicians as well. I am still on medication and my body does not feel right, I am achy all the time and tired all the time.
7/31/21 pt had a positive COVID test that resulted in a hospitalization with COVID pneumonia; pt dc'd; 9/14/21 pt presents to ED with AMS; found to be hypoglycemic; interventions performed without improvement in mental status; transferred to ICU; intubated; persistent encephalopathy; palliatively extubated; placed in hospice where pt passed away from respiratory failure
numbness in her lips; swelling in her face; her tongue was feeling funny; her throat was feeling strange; she had itchiness to her right hand; started to develop hives; This is a spontaneous report from a contactable consumer (patient). A 61-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, on 01Feb2021 at 09:00 (at the age of 61-years-old) at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) on an unspecified date for COVID-19 immunisation. The patient experienced numbness in her lips, swelling in her face, her tongue was feeling funny, her throat was feeling strange, she had itchiness to her right hand, and started to develop hives on 01Feb2021. The clinical course was reported as follows: Approximately 3 hours after receiving the vaccine, the patient started to experience numbness in her lips, swelling in her face, her tongue was feeling funny, her throat was feeling strange, and she had itchiness to her right hand and started to develop hives. The patient stated that she cannot take diphenhydramine hydrochloride (BENADRYL), but she did take cetirizine hydrochloride (ZYRTEC) to help with the symptoms. The patient was still having symptoms at the time of reporting. Therapeutic measures were taken as a result of all of the events as aforementioned. The clinical outcome of numbness in her lips, swelling in her face, her tongue was feeling funny, her throat was feeling strange, she had itchiness to her right hand, and started to develop hives was not recovered.   The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Started with a mosquito bite sized hard lump on the left arm at admin site and then turned into larger (42 mm wide) indurated/red area, warm to touch and radiates into shoulder.
right leg/knee became severely swollen; right leg/knee became severely swollen; couldn't walk; fatigue; fever; aches; This is a spontaneous report from a contactable consumer (patient). A 74-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN5318), via an unspecified route of administration, administered in left arm on 18Feb2021 at 12:00 (at the age of 74-year-old), as first dose, single, for COVID-19 immunization at school or student health clinic. Medical history included high blood pressure. The patient had no known allergies. Concomitant medications included atorvastatin calcium (LIPITOR); morniflumate (FLOMAX) losartan potassium (LOSARTAN POTASSIUM) and plus more (unspecified). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient was never tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's right leg/knee became severely swollen and he couldn't walk and also the patient had fatigue, fever and aches on an unspecified date on 2021. The events were reported as non-serious. No treatment was received for the events. The outcome was reported as recovered on an unknown date in 2021 for the reported events.
Information has been received from a Registered nurse (certified) concerning her 18 year old daughter who on an unspecified date as a young child, was vaccinated with a dose of VARIVAX (Merck) (lot number, dose and route not reported). The Mother reported that on an unspecified date, her daughter had a rash caused by "strep" and confirmed that her daughter did not have chickenpox. It was reported that the patient had to drop out of college and was unable to work as an after school supervisor. It was unknown if the patient sought medical attention. At the time of the report, the patient's outcome was unknown. Rash caused by "strep" was considered to be disabling by the reporter. Additional information has been requested.
Ran fever of 102`102.5 Through out the night. Chills, Head hurt, eyes hurt. Nauseated, Arm extremely painful.  Kept Symptons up un til 02/26/2021.  All symptoms seem to be gone now but arm is still sore and painful.  Do not plan to get second shot. I did have  Covid in April 2020 and was in the Hospital for 9 days. I don't know if that may have made me have the symptoms after receiving  this shot.
intermittant h/a; frontal & temporal w/hot & cold feeling; temp not measured;
A week after 2nd Pfizer vaccine old MS symptoms reoccurred.Thoracic radiculopathy, increased R side weakness, forgetfulness, bad headaches. improved somewhat. Now have ringing in ears-new symptom.
Chills, headaches, joint pains, muscle pains, fatigue, nausea.
Pt's mother called on Tuesday 07/29 and said her daughter had a seizure about 1 hour after injections. She did not seek medical attention.
area of erythema 6x3 cm adjacent to & including vax site, local fever;
Two weeks following each injection, Patient began to experience extreme dizziness accompanied with nausea and extreme fatigue, regardless of body position. This lasted for 2 weeks, gradually subsiding during the second week and resolved by the end of the second week following injection. She found relief from the nausea by taking ondansetron, which she had on hand.
I often run about a degree below normal.  When I feel like I'm warmer, I start taking my temperature.  I was also warned from someone I had been exposed to COVID-19 Saturday evening prior.  I had post nasal drip and my sinuses were stuffy.  My symptoms were continuing like I had a bad cold.  I went to a drive-up PCR test location for testing.  My doctor then prescribed Paxlovid for me.
Duplicate dose of PREVNAR 13, pt had received 1st dose on 10/1/18. No adverse symptoms reported by pt from 2nd injection.
Child given MMR and MMRV vaccines, should have received MMR and varicella vaccines. Spoke with father by phone, states child had no reactions from vaccines.
Raised red itchy rash  started on face then arms and finally whole body. Flushed and hot. Slight temperature just below 100F Benadryl tablets alleviated. Throughout the day and night. Gone in 12 hours.
Irregular macular rash appeared 07/24/2006- E. Multiforme appearance resolved in approximately 48 hours.
Flushed, warm face hot, scratchy throat. Pain in R arm, 4 cm edema, erythema, warmth deltoid, Rx: Benadryl, Solumedrol. 12/2/2009 PCP records for 11/5-11/6/2009, patient with c/o's feeling flushed, scratchy throat, itching at injection site and pain in rt arm. Rx'd Steroids and benadryl. 11/6/2009 sx were resolving.   12/09/09 Vaccine record received for DOS 11/05/09.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. It was reported that five vials of ZOSTAVAX had black particles in the product, as well as one of the vials that were punctured did not have enough product inside after reconstitution. Product quality complaint was involved in this case. The reporter stated because of all these vials having a defect, the patient had missed a dose. The patient did not experience any adverse effects. Additional information has been requested.
pt has severe fear of needles, reports always gets dizzy on any shot that she has ever had previously, after shot administered pt reported more severe dizziness than normal and seeing spots, had pt lay in supine position while call 911, pt seemed breathy but said she was just nervous and denied trouble breathing, EMS arrives, evaluated pt, and the went home on their own after sx resolved without any medical intervention, all vitals fine, pt encouraged to contact PCP, I reached out as well and left message for prescriber
Upper body burning only at night without fever. Onset the night after vaccination date. Lasted for two nights.  Extreme fatigue. started a day after vaccination and lasted for 3 days.
Fatigue, followed by headache, fever, chills, soreness and rash at injection site.
had the shingles shot and now has Gillian Bare; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In May 2022, the patient received Shingles vaccine. In May 2022, less than 3 weeks after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was not recovered/not resolved.   It was unknown if the reporter considered the guillain barre syndrome to be related to Shingles vaccine.     Additional Information: GSK receipt date: 21-May-2022 Reporter's comment: The case was received from the patient's son/ daughter via interactive digital media. The reporter' father just had the shingles shot 3 weeks ago and now he has had guillain barre syndrome. The reporter want people to knew that you can get it from the shot . Additional Supportive Information: Follow-up could not be possible as no contact details were available.
PROQUAD underwent a temperature excursion and was administered; This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and gender. On 11-JUN-2021, the patient was vaccinated with a dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot # T036562 exp date 26-APR-2022) rHA (dose and route not reported) that underwent a temperature excursion. Previous temperature of excursion was 6°F to 14°F (14F) for 2 hours, 14°F to 46°F (45.5F) 1 hour and 30 minutes and 6°F t o14°F (14.4F) for 2 hours.  This is one of several reports received from the same source.; Sender's Comments:  US-009507513-2106USA006475: US-009507513-2106USA006476: US-009507513-2106USA006477: US-009507513-2106USA006478: US-009507513-2106USA006479: US-009507513-2106USA006480: US-009507513-2106USA006481: US-009507513-2106USA006482: US-009507513-2106USA006483: US-009507513-2106USA006484: US-009507513-2106USA006485: US-009507513-2106USA006486: US-009507513-2106USA006487: US-009507513-2106USA006488: US-009507513-2106USA006489: US-009507513-2106USA006490: US-009507513-2106USA006491: US-009507513-2106USA006492: US-009507513-2106USA006064: US-009507513-2106USA006494: US-009507513-2106USA006495: US-009507513-2106USA006496: US-009507513-2106USA006497: US-009507513-2106USA006498: US-009507513-2106USA006458: US-009507513-2106USA006459: US-009507513-2106USA006460: US-009507513-2106USA006461: US-009507513-2106USA006462: US-009507513-2106USA006463: US-009507513-2106USA006464: US-009507513-2106USA006465: US-009507513-2106USA006466: US-009507513-2106USA006467: US-009507513-2106USA006468: US-009507513-2106USA006469: US-009507513-2106USA006470: US-009507513-2106USA006471: US-009507513-2106USA006472: US-009507513-2106USA006473: US-009507513-2106USA006474:
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 59-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Feb2021 as dose 1, single (Lot number: EN6203), on 21Mar2021 as dose 2, single (Lot number: ER8727), on 02Nov2021 as dose 3 (booster), single (Batch/Lot number: unknown) and on 27May2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 59 years for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "hypothyroidism" (unspecified if ongoing); "rosacea" (unspecified if ongoing); "osteopenia" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: 02Feb2022, stop date: 14Jul2022; ORACEA [DOXYCYCLINE], start date: 01Nov2021, stop date: 14Jul2022; VITAMIN D3, start date: 01Jan2021, stop date: 14Jun2022. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 11Jul2022, outcome "not recovered" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19. Clinical course: Anti-viral COVID-19 treatment with Paxlovid (Lot: GC9416) from 11Jul2022 to 12Jul2022. First dose of Paxlovid at 10 PM 11Jul2022; second dose 12Jul2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
One week after receiving the first vaccine, I developed severe headaches. I got my booster 21 days later. One week after receiving the booster, I started having severe headaches, severe neck, back and abdominal pain. I went to the ED the morning of 3/5/21, was admitted to the hospital and release on 3/8/21. It is in the H&P from Health facility.
pain at injection site; sporadic headaches; experienced problems concentrating; brain was totally different than it was before that shot. it was odd; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A 64-year-old female patient received bnt162b2 (BNT162B2), administration date 29Apr2021 (Lot number: EW0171) at the age of 64 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Covid-19" (unspecified if ongoing), notes: diagnosed with Covid back in the fall prior to vaccination. Concomitant medication(s) included: PROPRANOLOL taken for gastroesophageal reflux disease. The following information was reported: VACCINATION SITE PAIN (non-serious), outcome "unknown", described as "pain at injection site"; HEADACHE (non-serious), outcome "not recovered", described as "sporadic headaches"; DISTURBANCE IN ATTENTION (non-serious), outcome "not recovered", described as "experienced problems concentrating"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "brain was totally different than it was before that shot. it was odd". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of vaccination site pain, headache, disturbance in attention.  Additional information: The patient had her first Pfizer Covid-19 Vaccine on 29April2021 (2 weeks ago), The patient has been experiencing trouble concentrating and headache. The patient brain was totally different than it was before that shot. it was odd. A few days out she started to have pain at injection site (she was aware of its effect), sporadic headaches. Pain mostly seemed on the left side of her head. The patient was treated with Aspirin or Advil (the patient stated that she had to take a 325 milligrams Aspirin, 2 of them at one dose, 1 Advil, whatever it was, that, it was 200 mg).  No follow-up attempts are possible. No further information is expected.
contracted COVID infection chills;headache;anosmia/dysgeusia;congestion/rhinorrhea